Business Context and Reporting Period
Company: Surgery Partners, Inc. (SGRY)
Filing Type: Form 8-K (Current Report)
Date of Report: August 21, 2024
Reporting Period: Immediate event reporting regarding a change in independent registered public accounting firm.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance regarding the external auditor.
Material Changes
- Dismissal of Auditor: The Audit Committee dismissed Deloitte & Touche LLP as the independent registered public accounting firm, effective August 21, 2024.
- Engagement of New Auditor: The Audit Committee engaged Ernst & Young LLP (EY) as the new independent registered public accounting firm to audit the fiscal year ending December 31, 2024, effective August 21, 2024.
- Audit History: Deloitte's reports for fiscal years 2023 and 2022 contained no adverse opinions, disclaimers, or qualifications.
- Disagreements: The Company reported no disagreements with Deloitte regarding accounting principles, practices, or audit scope during the relevant periods.
- Consultations: The Company did not consult with EY regarding accounting principles or audit opinions prior to engagement.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary on business operations. The primary risk disclosed is the transition of the external audit firm, though the Company states there were no reportable events or disagreements necessitating the change.
Investor Verification Checklist
- Verify the content of Deloitte's letter to the SEC (Exhibit 16) to confirm their agreement with the Company's statements regarding the dismissal.
- Monitor future filings for the rationale behind the auditor change, as the 8-K does not explicitly state the reason for dismissal.
- Review the upcoming 10-K for the fiscal year ending December 31, 2024, to assess the impact of the auditor transition on the audit process and timeline.
- Confirm that no undisclosed disagreements or reportable events exist by cross-referencing with subsequent regulatory communications.